Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release - PubMed (original) (raw)
Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release
R A Weldon Jr et al. J Virol. 1993 Sep.
Abstract
Retroviral Gag proteins have the ability to induce budding and particle release from the plasma membrane when expressed in the absence of all of the other virus-encoded components; however, the locations of the functional domains within the Gag protein that are important for this process are poorly understood. It was shown previously that the protease sequence of the Rous sarcoma virus (RSV) Gag protein can be replaced with a foreign polypeptide, iso-1-cytochrome c from a yeast, without disrupting particle assembly (R. A. Weldon, Jr., C. R. Erdie, M. G. Oliver, and J. W. Wills, J. Virol. 64:4169-4179, 1990). An unexpected product of the chimeric gag gene is a small, Gag-related protein named p25C. This product was of interest because of its high efficiency of packaging into particles. The goal of the experiments described here was to determine the mechanism by which p25C is synthesized and packaged into particles. The results demonstrate that it is not the product of proteolytic processing of the Gag-cytochrome precursor but is derived from an unusual spliced mRNA. cDNA clones of the spliced mRNA were obtained, and each expressed a product of approximately 25 kDa, designated p25M1, which was released into the growth medium in membrane-enclosed particles that were much lighter than authentic retrovirions as measured in sucrose density gradients. DNA sequencing revealed that the clones encode the first 180 of the 701 amino acids of the RSV Gag protein and no residues from iso-1-cytochrome c. This suggested that a domain in the carboxy-terminal half of Gag is important for the packaging of Gag proteins into dense arrays within the particles. In support of this hypothesis, particles of the correct density were obtained when a small segment from the carboxy terminus of the RSV Gag protein (residues 417 to 584) was included on the end of p25.
Similar articles
- Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.
Bennett RP, Nelle TD, Wills JW. Bennett RP, et al. J Virol. 1993 Nov;67(11):6487-98. doi: 10.1128/JVI.67.11.6487-6498.1993. J Virol. 1993. PMID: 8411352 Free PMC article. - Incorporation of chimeric gag protein into retroviral particles.
Weldon RA Jr, Erdie CR, Oliver MG, Wills JW. Weldon RA Jr, et al. J Virol. 1990 Sep;64(9):4169-79. doi: 10.1128/JVI.64.9.4169-4179.1990. J Virol. 1990. PMID: 2166812 Free PMC article. - Amino acids encoded downstream of gag are not required by Rous sarcoma virus protease during gag-mediated assembly.
Bennett RP, Rhee S, Craven RC, Hunter E, Wills JW. Bennett RP, et al. J Virol. 1991 Jan;65(1):272-80. doi: 10.1128/JVI.65.1.272-280.1991. J Virol. 1991. PMID: 1845888 Free PMC article. - An assembly domain of the Rous sarcoma virus Gag protein required late in budding.
Wills JW, Cameron CE, Wilson CB, Xiang Y, Bennett RP, Leis J. Wills JW, et al. J Virol. 1994 Oct;68(10):6605-18. doi: 10.1128/JVI.68.10.6605-6618.1994. J Virol. 1994. PMID: 8083996 Free PMC article. - Replication-competent retroviral vectors for expressing genes in avian cells in vitro and in vivo.
Bell EJ, Brickell PM. Bell EJ, et al. Mol Biotechnol. 1997 Jun;7(3):289-98. doi: 10.1007/BF02740819. Mol Biotechnol. 1997. PMID: 9219242 Review.
Cited by
- The Rous sarcoma virus Gag Polyprotein Forms Biomolecular Condensates Driven by Intrinsically-disordered Regions.
Kaddis Maldonado R, Lambert GS, Rice BL, Sudol M, Flanagan JM, Parent LJ. Kaddis Maldonado R, et al. J Mol Biol. 2023 Aug 15;435(16):168182. doi: 10.1016/j.jmb.2023.168182. Epub 2023 Jun 14. J Mol Biol. 2023. PMID: 37328094 Free PMC article. - Contributions of Charged Residues in Structurally Dynamic Capsid Surface Loops to Rous Sarcoma Virus Assembly.
Heyrana KJ, Goh BC, Perilla JR, Nguyen TN, England MR, Bewley MC, Schulten K, Craven RC. Heyrana KJ, et al. J Virol. 2016 May 27;90(12):5700-5714. doi: 10.1128/JVI.00378-16. Print 2016 Jun 15. J Virol. 2016. PMID: 27053549 Free PMC article. - Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.
Rye-McCurdy TD, Nadaraia-Hoke S, Gudleski-O'Regan N, Flanagan JM, Parent LJ, Musier-Forsyth K. Rye-McCurdy TD, et al. J Virol. 2014 Jul;88(14):7852-61. doi: 10.1128/JVI.00736-14. Epub 2014 Apr 30. J Virol. 2014. PMID: 24789780 Free PMC article. - Fluorosomes: fluorescent virus-like nanoparticles that represent a convenient tool to visualize receptor-ligand interactions.
Wojta-Stremayr D, Pickl WF. Wojta-Stremayr D, et al. Sensors (Basel). 2013 Jul 8;13(7):8722-49. doi: 10.3390/s130708722. Sensors (Basel). 2013. PMID: 23881135 Free PMC article. Review. - Arenavirus budding resulting from viral-protein-associated cell membrane curvature.
Schley D, Whittaker RJ, Neuman BW. Schley D, et al. J R Soc Interface. 2013 Jul 17;10(86):20130403. doi: 10.1098/rsif.2013.0403. Print 2013 Sep 6. J R Soc Interface. 2013. PMID: 23864502 Free PMC article.
References
- J Virol. 1988 Sep;62(9):3328-33 - PubMed
- J Gen Virol. 1992 Dec;73 ( Pt 12):3079-86 - PubMed
- J Virol. 1989 Apr;63(4):1558-68 - PubMed
- Cell. 1989 Jul 28;58(2):281-6 - PubMed
- J Virol. 1989 Oct;63(10):4331-43 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources